secwatch.observer — SEC 8-K summary
======================================

Issuer:     ENvue Medical, Inc. (FEED)
CIK:        0001326706
Form:       8-K
Filed at:   2025-11-19T23:59:59+00:00
Accession:  0001493152-25-024167
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 7.01
LLM model:  deepseek-v4-flash:cloud@v2

NanoVibronix to rebrand as ENvue Medical, focus on enteral-feeding navigation platform
--------------------------------------------------------------------------------

- ENvue feeding-tube placement system identified as core growth platform; 38 hospitals already using it.
- U.S. enteral-feeding devices market projected at ~$1.8B by 2030; ENvue is 510(k)-cleared for adults.
- Company planning name change to ENvue Medical and new NASDAQ ticker symbol.
- Exploring strategic alternatives (partnerships/divestitures) for legacy PainShield and UroShield technologies.
- CEO Doron Besser (appointed June 2025) outlines multi-phase roadmap including pediatric, imaging, and vascular applications.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1326706/000149315225024167/0001493152-25-024167-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1326706/000149315225024167/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-024167

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer